Key result
In a 66-year-old man with severe neuroleptic malignant syndrome requiring invasive ventilation, treatment with electroconvulsive therapy and bromocriptine led to significant clinical recovery.
Why the study?
Neuroleptic malignant syndrome can have a heterogeneous and non-specific presentation, leading to delays in diagnosis and treatment.
Case Report (n=1)
No
Electroconvulsive therapy and bromocriptine can be effective for severe neuroleptic malignant syndrome in critically ill patients.
No takes yet. Share an insight, caveat, or question.
May support electroconvulsive therapy plus bromocriptine in refractory neuroleptic malignant syndrome; hypothesis-generating and requires prospective validation.
Maia et al. (2020) conducted a case report in Neuroleptic Malignant Syndrome (n=1). Electroconvulsive therapy and bromocriptine was evaluated on Clinical recovery (Bush-Francis Catatonia Rating Scale score). In a 66-year-old man with severe neuroleptic malignant syndrome requiring invasive ventilation, treatment with electroconvulsive therapy and bromocriptine led to significant clinical recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: